Consultations

Search consultations and choose filters to show only the results you want

Filter search results

Topic

Publication date

Department

2016 consultations

Equality and Human Rights Consultation - NICE TA - Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma

Published 05 June 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Adalimumab and Dexamethasone for Treating Non-Infectious Uveitis

Published 05 June 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 69 - Eating Disorders: Recognition and Treatment

Published 23 May 2017ClosedDepartment of Health

Consultation on Amending the Environmental Impact Assessment (Agriculture) Regulations (Northern Ireland) 2007

Published 22 May 2017ClosedDepartment of Agriculture, Environment and Rural Affairs

Equality and Human Rights Consultation - NICE TA - Etelcalcetide for treating secondary hyperparathyroidism

Published 19 May 2017ClosedDepartment of Health

Environmental Impact Assessment - Raw, Brookeborough, Co. Fermanagh

Published 15 May 2017ClosedDepartment of Agriculture, Environment and Rural Affairs

Environmental Impact Assessment - Tullykittagh, Clough, Co. Antrim

Published 15 May 2017ClosedDepartment of Agriculture, Environment and Rural Affairs

Environmental Impact Assessment - Inishatieve, Carrickmore, Co. Tyrone

Published 15 May 2017ClosedDepartment of Agriculture, Environment and Rural Affairs

Equality and Human Rights Consultation - NICE TA - Everolimus, Lutetium-177 DOTATATE and Sunitinib for Treating Unresectable or Metastatic Neuroendocrine Tumours with Disease Progression

Published 12 May 2017ClosedDepartment of Health

Consultation on a draft revised UK Air Quality Plan for tackling nitrogen dioxide

Published 05 May 2017ClosedDepartment of Agriculture, Environment and Rural Affairs

Equality and Human Rights Consultation - NICE TA - Brentuximab Vedotin for Treating CD30-Positive Hodgkin’s Lymphoma

Published 28 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Blinatumomab for treating Philadelphia-chromosome-negative relapsed or refractory acute lymphoblastic leukaemia

Published 28 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Ustekinumab for moderately to severely active Crohn’s disease after previous treatment

Published 28 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Ponatinib for Treating Chronic Myeloid Leukaemia and Acute Lymphoblastic Leukaemia

Published 28 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Certolizumab Pegol and Secukinumab for Treating Active Psoriatic Arthritis Following Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Published 24 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG63 - Sexually Transmitted Infections: Condom Distribution Schemes

Published 06 April 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer after Gemcitabine

Published 28 March 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE NG 66 - Mental Health of Adults in Contact with the Criminal Justice System

Published 22 March 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Daclizumab for Treating Relapsing-Remitting Multiple Sclerosis

Published 15 March 2017ClosedDepartment of Health

Equality and Human Rights Consultation - NICE TA - Ixekizumab for Treating Moderate to Severe Plaque Psoriasis

Published 10 March 2017ClosedDepartment of Health

Pages

Back to top